GenRx Entecavir entecavir (as monohydrate) 0.5mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

entecavir, Quantity: 0.5 mg

Saadav alates:

Arrotex Pharmaceuticals Pty Ltd

INN (Rahvusvaheline Nimetus):

Entecavir

Ravimvorm:

Tablet

Koostis:

Excipient Ingredients: lactose monohydrate; magnesium stearate; macrogol 8000; microcrystalline cellulose; hyprolose; copovidone; hypromellose; crospovidone; titanium dioxide

Manustamisviis:

Oral

Ühikuid pakis:

30

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Toote kokkuvõte:

Visual Identification: White colored, triangular shaped film coated tablets, engraved 'APO' on one side and '0.5' over 'ENT' on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2016-03-10